PharmaCyte Biotech, Inc. - PMCB
Sector:
Healthcare
· Industry:
Biological Products, (No Diagnostic Substances)
Website:
No information yet
· Social:
No information yet
Company profile
Powered by TradingView
Quarter snapshot
Latest / Compare
Q3 2026
· Q2 2026
Value (USD)
Total reported value ($000)
$647K
QoQ value delta ($000)
+$1K
(+0.15%)
Implied price effect (QoQ)
-2.15%
Shares
Total shares
868,869
QoQ shares delta
+19,999
(+2.36%)
Total shares held by funds (by quarter)
Shares (left)
Fund holders (right)
Market chart (PMCB)
Powered by TradingView
Interactive chart by
TradingView.
Top holders (Q3 2026)
Top 25 only
Full list
Partial Q3 2026 data: 6 holders have filed so far. Prior holders are carried forward until their next 13F confirms a change.
| Manager | Value ($000) | Shares | % of 13F |
|---|---|---|---|
| CITADEL ADVISORS LLC | 284 | 369,481 | 0.0% |
| GEODE CAPITAL MANAGEMENT, LLC | 95 | 124,247 | 0.0% |
| VANGUARD CAPITAL MANAGEMENT LLC | 43 | 56,778 | 0.0% |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 34 | 44,853 | 0.0% |
| RENAISSANCE TECHNOLOGIES LLC | 29 | 37,987 | 0.0% |
| XTX Topco Ltd | 26 | 34,180 | 0.0% |
| NORTHERN TRUST CORP | 25 | 32,624 | 0.0% |
| JANE STREET GROUP, LLC | 23 | 30,064 | 0.0% |
| Schonfeld Strategic Advisors LLC | 20 | 26,926 | 0.0% |
| VANGUARD FIDUCIARY TRUST CO | 18 | 23,452 | 0.0% |
| EQUITEC PROPRIETARY MARKETS, LLC | 17 | 22,227 | 0.0% |
| StoneX Group Inc. | 12 | 30,006 | 0.0% |
| HRT FINANCIAL LP | 11 | 15,451 | 0.0% |
| COMMONWEALTH EQUITY SERVICES, LLC | 4 | 10,255 | 0.0% |
| Tower Research Capital LLC (TRC) | 3 | 4,888 | 0.0% |
| UBS Group AG | 3 | 4,142 | 0.0% |
| HUNTINGTON NATIONAL BANK | 0 | 1 | 0.0% |
| BARCLAYS PLC | 0 | 192 | 0.0% |
| CALDWELL SUTTER CAPITAL, INC. | 0 | 2 | 0.0% |
| HARBOUR INVESTMENTS, INC. | 0 | 3 | 0.0% |
| MORGAN STANLEY | 0 | 2 | 0.0% |
| GROUP ONE TRADING LLC | 0 | 500 | 0.0% |
| Johnson Financial Group, Inc. | 0 | 1 | 0.0% |
| FINANCIAL CONSULATE, INC | 0 | 2 | 0.0% |
| NewEdge Advisors, LLC | 0 | 2 | 0.0% |